Inogen, Inc. (NASDAQ:INGN) Short Interest Down 6.2% in December

Inogen, Inc. (NASDAQ:INGN) was the recipient of a significant drop in short interest during the month of December. As of December 31st, there was short interest totalling 714,200 shares, a drop of 6.2% from the December 15th total of 761,300 shares. Based on an average trading volume of 187,000 shares, the days-to-cover ratio is presently 3.8 days.

Analysts Set New Price Targets

A number of brokerages have commented on INGN. StockNews.com cut shares of Inogen from a “buy” rating to a “hold” rating in a research note on Friday, December 20th. Needham & Company LLC reiterated a “hold” rating on shares of Inogen in a research note on Tuesday, January 14th.

Institutional Trading of Inogen

Hedge funds have recently modified their holdings of the stock. Connor Clark & Lunn Investment Management Ltd. lifted its stake in shares of Inogen by 312.5% during the 3rd quarter. Connor Clark & Lunn Investment Management Ltd. now owns 174,625 shares of the medical technology company’s stock worth $1,694,000 after buying an additional 132,287 shares during the last quarter. JPMorgan Chase & Co. increased its position in Inogen by 2.7% during the third quarter. JPMorgan Chase & Co. now owns 896,106 shares of the medical technology company’s stock worth $8,692,000 after acquiring an additional 23,891 shares during the period. Barclays PLC increased its position in Inogen by 72.9% during the third quarter. Barclays PLC now owns 55,508 shares of the medical technology company’s stock worth $539,000 after acquiring an additional 23,398 shares during the period. B. Riley Wealth Advisors Inc. bought a new position in Inogen during the second quarter worth about $457,000. Finally, Geode Capital Management LLC increased its position in Inogen by 1.1% during the third quarter. Geode Capital Management LLC now owns 554,191 shares of the medical technology company’s stock worth $5,377,000 after acquiring an additional 5,921 shares during the period. Institutional investors and hedge funds own 89.94% of the company’s stock.

Inogen Stock Performance

Shares of NASDAQ INGN traded down $0.05 during mid-day trading on Friday, reaching $10.47. 149,232 shares of the company were exchanged, compared to its average volume of 148,305. The company’s 50-day simple moving average is $9.53 and its 200-day simple moving average is $9.94. Inogen has a twelve month low of $5.08 and a twelve month high of $13.33.

About Inogen

Inogen, Inc, a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions.